Kelsey writes: “It’s sad that the US government opposes this approach. It also confuses me why the UK is pledging 60 million to help start the “free” market. Maybe they need that much to study it?” I’m having a hard time understanding this as well. It sounds like free-market economist, Kenneth Arrow, pointed out that public initiatives to distribute anti-malaria drugs are less effective than private initiatives. The proposed solution: Pharmaceutical wholesalers in poor countries should be able to buy [state-of-the-art malaria drugs] straight from the manufacturer for pennies instead of dollars, the panel said; donors would pay the difference … Continue reading Getting Malaria Drugs to Market